Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Enasidenib market report explains the definition, types, applications, major countries, and major players of the Enasidenib market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Celgene Corporation
By Type:
50mg
100mg
By End-User:
Hospital
Pharmacy
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Enasidenib Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Enasidenib Outlook to 2028- Original Forecasts
-
2.2 Enasidenib Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Enasidenib Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Enasidenib Market- Recent Developments
-
6.1 Enasidenib Market News and Developments
-
6.2 Enasidenib Market Deals Landscape
7 Enasidenib Raw Materials and Cost Structure Analysis
-
7.1 Enasidenib Key Raw Materials
-
7.2 Enasidenib Price Trend of Key Raw Materials
-
7.3 Enasidenib Key Suppliers of Raw Materials
-
7.4 Enasidenib Market Concentration Rate of Raw Materials
-
7.5 Enasidenib Cost Structure Analysis
-
7.5.1 Enasidenib Raw Materials Analysis
-
7.5.2 Enasidenib Labor Cost Analysis
-
7.5.3 Enasidenib Manufacturing Expenses Analysis
8 Global Enasidenib Import and Export Analysis (Top 10 Countries)
-
8.1 Global Enasidenib Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Enasidenib Export by Region (Top 10 Countries) (2017-2028)
9 Global Enasidenib Market Outlook by Types and Applications to 2022
-
9.1 Global Enasidenib Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global 50mg Consumption and Growth Rate (2017-2022)
-
9.1.2 Global 100mg Consumption and Growth Rate (2017-2022)
-
9.2 Global Enasidenib Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Pharmacy Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Enasidenib Market Analysis and Outlook till 2022
-
10.1 Global Enasidenib Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Enasidenib Consumption (2017-2022)
-
10.2.2 Canada Enasidenib Consumption (2017-2022)
-
10.2.3 Mexico Enasidenib Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Enasidenib Consumption (2017-2022)
-
10.3.2 UK Enasidenib Consumption (2017-2022)
-
10.3.3 Spain Enasidenib Consumption (2017-2022)
-
10.3.4 Belgium Enasidenib Consumption (2017-2022)
-
10.3.5 France Enasidenib Consumption (2017-2022)
-
10.3.6 Italy Enasidenib Consumption (2017-2022)
-
10.3.7 Denmark Enasidenib Consumption (2017-2022)
-
10.3.8 Finland Enasidenib Consumption (2017-2022)
-
10.3.9 Norway Enasidenib Consumption (2017-2022)
-
10.3.10 Sweden Enasidenib Consumption (2017-2022)
-
10.3.11 Poland Enasidenib Consumption (2017-2022)
-
10.3.12 Russia Enasidenib Consumption (2017-2022)
-
10.3.13 Turkey Enasidenib Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Enasidenib Consumption (2017-2022)
-
10.4.2 Japan Enasidenib Consumption (2017-2022)
-
10.4.3 India Enasidenib Consumption (2017-2022)
-
10.4.4 South Korea Enasidenib Consumption (2017-2022)
-
10.4.5 Pakistan Enasidenib Consumption (2017-2022)
-
10.4.6 Bangladesh Enasidenib Consumption (2017-2022)
-
10.4.7 Indonesia Enasidenib Consumption (2017-2022)
-
10.4.8 Thailand Enasidenib Consumption (2017-2022)
-
10.4.9 Singapore Enasidenib Consumption (2017-2022)
-
10.4.10 Malaysia Enasidenib Consumption (2017-2022)
-
10.4.11 Philippines Enasidenib Consumption (2017-2022)
-
10.4.12 Vietnam Enasidenib Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Enasidenib Consumption (2017-2022)
-
10.5.2 Colombia Enasidenib Consumption (2017-2022)
-
10.5.3 Chile Enasidenib Consumption (2017-2022)
-
10.5.4 Argentina Enasidenib Consumption (2017-2022)
-
10.5.5 Venezuela Enasidenib Consumption (2017-2022)
-
10.5.6 Peru Enasidenib Consumption (2017-2022)
-
10.5.7 Puerto Rico Enasidenib Consumption (2017-2022)
-
10.5.8 Ecuador Enasidenib Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Enasidenib Consumption (2017-2022)
-
10.6.2 Kuwait Enasidenib Consumption (2017-2022)
-
10.6.3 Oman Enasidenib Consumption (2017-2022)
-
10.6.4 Qatar Enasidenib Consumption (2017-2022)
-
10.6.5 Saudi Arabia Enasidenib Consumption (2017-2022)
-
10.6.6 United Arab Emirates Enasidenib Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Enasidenib Consumption (2017-2022)
-
10.7.2 South Africa Enasidenib Consumption (2017-2022)
-
10.7.3 Egypt Enasidenib Consumption (2017-2022)
-
10.7.4 Algeria Enasidenib Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Enasidenib Consumption (2017-2022)
-
10.8.2 New Zealand Enasidenib Consumption (2017-2022)
11 Global Enasidenib Competitive Analysis
-
11.1 Celgene Corporation
-
11.1.1 Celgene Corporation Company Details
-
11.1.2 Celgene Corporation Enasidenib Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Celgene Corporation Enasidenib Main Business and Markets Served
-
11.1.4 Celgene Corporation Enasidenib Product Portfolio
-
11.1.5 Recent Research and Development Strategies
12 Global Enasidenib Market Outlook by Types and Applications to 2028
-
12.1 Global Enasidenib Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global 50mg Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global 100mg Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Enasidenib Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Pharmacy Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Enasidenib Market Analysis and Outlook to 2028
-
13.1 Global Enasidenib Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Enasidenib Consumption Forecast (2022-2028)
-
13.2.2 Canada Enasidenib Consumption Forecast (2022-2028)
-
13.2.3 Mexico Enasidenib Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Enasidenib Consumption Forecast (2022-2028)
-
13.3.2 UK Enasidenib Consumption Forecast (2022-2028)
-
13.3.3 Spain Enasidenib Consumption Forecast (2022-2028)
-
13.3.4 Belgium Enasidenib Consumption Forecast (2022-2028)
-
13.3.5 France Enasidenib Consumption Forecast (2022-2028)
-
13.3.6 Italy Enasidenib Consumption Forecast (2022-2028)
-
13.3.7 Denmark Enasidenib Consumption Forecast (2022-2028)
-
13.3.8 Finland Enasidenib Consumption Forecast (2022-2028)
-
13.3.9 Norway Enasidenib Consumption Forecast (2022-2028)
-
13.3.10 Sweden Enasidenib Consumption Forecast (2022-2028)
-
13.3.11 Poland Enasidenib Consumption Forecast (2022-2028)
-
13.3.12 Russia Enasidenib Consumption Forecast (2022-2028)
-
13.3.13 Turkey Enasidenib Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Enasidenib Consumption Forecast (2022-2028)
-
13.4.2 Japan Enasidenib Consumption Forecast (2022-2028)
-
13.4.3 India Enasidenib Consumption Forecast (2022-2028)
-
13.4.4 South Korea Enasidenib Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Enasidenib Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Enasidenib Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Enasidenib Consumption Forecast (2022-2028)
-
13.4.8 Thailand Enasidenib Consumption Forecast (2022-2028)
-
13.4.9 Singapore Enasidenib Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Enasidenib Consumption Forecast (2022-2028)
-
13.4.11 Philippines Enasidenib Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Enasidenib Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Enasidenib Consumption Forecast (2022-2028)
-
13.5.2 Colombia Enasidenib Consumption Forecast (2022-2028)
-
13.5.3 Chile Enasidenib Consumption Forecast (2022-2028)
-
13.5.4 Argentina Enasidenib Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Enasidenib Consumption Forecast (2022-2028)
-
13.5.6 Peru Enasidenib Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Enasidenib Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Enasidenib Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Enasidenib Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Enasidenib Consumption Forecast (2022-2028)
-
13.6.3 Oman Enasidenib Consumption Forecast (2022-2028)
-
13.6.4 Qatar Enasidenib Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Enasidenib Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Enasidenib Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Enasidenib Consumption Forecast (2022-2028)
-
13.7.2 South Africa Enasidenib Consumption Forecast (2022-2028)
-
13.7.3 Egypt Enasidenib Consumption Forecast (2022-2028)
-
13.7.4 Algeria Enasidenib Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Enasidenib Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Enasidenib Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Enasidenib
-
Figure of Enasidenib Picture
-
Table Global Enasidenib Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Enasidenib Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global 50mg Consumption and Growth Rate (2017-2022)
-
Figure Global 100mg Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Pharmacy Consumption and Growth Rate (2017-2022)
-
Figure Global Enasidenib Consumption by Country (2017-2022)
-
Table North America Enasidenib Consumption by Country (2017-2022)
-
Figure United States Enasidenib Consumption and Growth Rate (2017-2022)
-
Figure Canada Enasidenib Consumption and Growth Rate (2017-2022)
-
Figure Mexico Enasidenib Consumption and Growth Rate (2017-2022)
-
Table Europe Enasidenib Consumption by Country (2017-2022)
-
Figure Germany Enasidenib Consumption and Growth Rate (2017-2022)
-
Figure UK Enasidenib Consumption and Growth Rate (2017-2022)
-
Figure Spain Enasidenib Consumption and Growth Rate (2017-2022)
-
Figure Belgium Enasidenib Consumption and Growth Rate (2017-2022)
-
Figure France Enasidenib Consumption and Growth Rate (2017-2022)
-
Figure Italy Enasidenib Consumption and Growth Rate (2017-2022)
-
Figure Denmark Enasidenib Consumption and Growth Rate (2017-2022)
-
Figure Finland Enasidenib Consumption and Growth Rate (2017-2022)
-
Figure Norway Enasidenib Consumption and Growth Rate (2017-2022)
-
Figure Sweden Enasidenib Consumption and Growth Rate (2017-2022)
-
Figure Poland Enasidenib Consumption and Growth Rate (2017-2022)
-
Figure Russia Enasidenib Consumption and Growth Rate (2017-2022)
-
Figure Turkey Enasidenib Consumption and Growth Rate (2017-2022)
-
Table APAC Enasidenib Consumption by Country (2017-2022)
-
Figure China Enasidenib Consumption and Growth Rate (2017-2022)
-
Figure Japan Enasidenib Consumption and Growth Rate (2017-2022)
-
Figure India Enasidenib Consumption and Growth Rate (2017-2022)
-
Figure South Korea Enasidenib Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Enasidenib Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Enasidenib Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Enasidenib Consumption and Growth Rate (2017-2022)
-
Figure Thailand Enasidenib Consumption and Growth Rate (2017-2022)
-
Figure Singapore Enasidenib Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Enasidenib Consumption and Growth Rate (2017-2022)
-
Figure Philippines Enasidenib Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Enasidenib Consumption and Growth Rate (2017-2022)
-
Table South America Enasidenib Consumption by Country (2017-2022)
-
Figure Brazil Enasidenib Consumption and Growth Rate (2017-2022)
-
Figure Colombia Enasidenib Consumption and Growth Rate (2017-2022)
-
Figure Chile Enasidenib Consumption and Growth Rate (2017-2022)
-
Figure Argentina Enasidenib Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Enasidenib Consumption and Growth Rate (2017-2022)
-
Figure Peru Enasidenib Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Enasidenib Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Enasidenib Consumption and Growth Rate (2017-2022)
-
Table GCC Enasidenib Consumption by Country (2017-2022)
-
Figure Bahrain Enasidenib Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Enasidenib Consumption and Growth Rate (2017-2022)
-
Figure Oman Enasidenib Consumption and Growth Rate (2017-2022)
-
Figure Qatar Enasidenib Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Enasidenib Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Enasidenib Consumption and Growth Rate (2017-2022)
-
Table Africa Enasidenib Consumption by Country (2017-2022)
-
Figure Nigeria Enasidenib Consumption and Growth Rate (2017-2022)
-
Figure South Africa Enasidenib Consumption and Growth Rate (2017-2022)
-
Figure Egypt Enasidenib Consumption and Growth Rate (2017-2022)
-
Figure Algeria Enasidenib Consumption and Growth Rate (2017-2022)
-
Table Oceania Enasidenib Consumption by Country (2017-2022)
-
Figure Australia Enasidenib Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Enasidenib Consumption and Growth Rate (2017-2022)
-
Table Celgene Corporation Company Details
-
Table Celgene Corporation Enasidenib Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celgene Corporation Enasidenib Main Business and Markets Served
-
Table Celgene Corporation Enasidenib Product Portfolio
-
Figure Global 50mg Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 100mg Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Enasidenib Consumption Forecast by Country (2022-2028)
-
Table North America Enasidenib Consumption Forecast by Country (2022-2028)
-
Figure United States Enasidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Enasidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Enasidenib Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Enasidenib Consumption Forecast by Country (2022-2028)
-
Figure Germany Enasidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Enasidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Enasidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Enasidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Enasidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Enasidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Enasidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Enasidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Enasidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Enasidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Enasidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Enasidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Enasidenib Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Enasidenib Consumption Forecast by Country (2022-2028)
-
Figure China Enasidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Enasidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Enasidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Enasidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Enasidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Enasidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Enasidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Enasidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Enasidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Enasidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Enasidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Enasidenib Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Enasidenib Consumption Forecast by Country (2022-2028)
-
Figure Brazil Enasidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Enasidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Enasidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Enasidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Enasidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Enasidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Enasidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Enasidenib Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Enasidenib Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Enasidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Enasidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Enasidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Enasidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Enasidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Enasidenib Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Enasidenib Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Enasidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Enasidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Enasidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Enasidenib Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Enasidenib Consumption Forecast by Country (2022-2028)
-
Figure Australia Enasidenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Enasidenib Consumption Forecast and Growth Rate (2022-2028)
-
